Do you want BuboFlash to help you learning these things? Or do you want to add or correct something? Click here to log in or create user.

In the field of transplantation, CMV serology is performed on blood samples from the prospective organ donor and recipient to determine the risk of primary infection or reactivation of disease. The knowledge of these risks influences the type of preventive efforts for each patient population. Specifically, a CMV D+/R- mismatch SOT recipient has the highest risk of primary CMV disease, and therefore may benefit from antiviral prophylaxis or aggressive CMV surveillance and pre- emptive therapy. Some centers have also used serology to determine ongoing risk of primary CMV disease after transplantation since seroconversion would suggest pro- tection from subsequent CMV disease
If you want to change selection, open document below and click on "Move attachment"


owner: memeyrie - (no access) - CMV ASM.pdf, p13


statusnot read reprioritisations
last reprioritisation on suggested re-reading day
started reading on finished reading on



Do you want to join discussion? Click here to log in or create user.